Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data-Reference-Cited by-同舟云学术

Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data

Published:2022-06 Issue: Volume:62 Page:103792
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Gitman Victor,Stavropoulos Aphrodite,Saenz Victoria,Pasquarelli Noemi,Zecevic Dusanka,Devonshire Virginia

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference32 articles.

1. Bove R., et al. B-Cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a Phase 4 study (SOPRANINO). Poster presented at ECTRIMS 2021 (P686).

2. Clinical outcomes in high-risk pregnancies due to advanced maternal age;Correa-de-Araujo;J. Womens Health,2021

3. Use of disease-modifying drugs during pregnancy and breastfeeding;Dobson;Curr. Opin. Neurol.,2021

4. Dobson, R., et al. Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. Poster presented at ECTIMS 2021 (P641).

5. Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study;Ebrahimi;Mult. Scler.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database;Pharmaceuticals;2023-11-06

2. Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective;Journal of Pharmacy & Pharmaceutical Sciences;2023-10-13

3. Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis;Journal of Neurology, Neurosurgery & Psychiatry;2023-02-20